TEHRAN (ANA)- A Japanese research institute announced Tuesday that the final phase of a clinical trial testing a Parkinson’s drug as a potential treatment for familial Alzheimer’s disease has been underway since May.
TEHRAN (ANA)- Scientists reveal that the brain’s apparent age may shape how health risks like high blood pressure affect thinking and memory, especially in people with signs of cerebrovascular disease.
TEHRAN (ANA)- A first-of-its-kind clinical trial has shown that ketamine’s effectiveness in treating severe depression can be enhanced when combined with psychotherapy and supportive care settings.
TEHRAN (ANA)- New research tracking over 10,000 adults for 16 years suggests that people with higher psychological well-being may experience better memory in midlife.
TEHRAN (ANA)- The ingestible capsule creates a drug depot in the stomach, slowly releasing its medication over time and removing the need for patients to take a daily dose.